Luigi Naldini

Luigi Naldini

Director/Board Member at
San Raffaele-Telethon Institute for Gene Therapy

Net worth: 3 M $ as of 30/06/2026

Health Technology
Consumer Services
Commercial Services

Profile

Luigi Naldini is the founder of Magenta Therapeutics, Inc. founded in 2015.
Dr. Naldini is the founder of Epsilen Bio Srl founded in 2019.
Dr. Naldini was the founder of Genenta Science SpA founded in 2014 and held the title of Chairman-Executive Scientific Board.
Dr. Naldini is the founder of GenAspire Srl founded in 2020.
Dr. Naldini is also the founder of nChroma Bio, Inc.,Chroma Medicine, Inc...
Dr. Naldini is Director at San Raffaele-Telethon Institute for Gene Therapy.
Dr. Naldini is Director at American Society of Gene & Cell Therapy.
Dr. Naldini is Professor at Università Vita-Salute San Raffaele.
Dr. Naldini was President at European Society of Gene & Cell Therapy.
Dr. Naldini earned doctorates from the University of Turin and Università degli Studi di Roma Tor Vergata.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
04/05/2026 1,386,145 ( 7.61% ) 3 M $ 30/06/2026

Luigi Naldini active positions

CompaniesPositionStart
San Raffaele-Telethon Institute for Gene Therapy
Director/Board Member -
Corporate Officer/Principal -
Director/Board Member -

Former positions of Luigi Naldini

CompaniesPositionEnd
Founder -
European Society of Gene & Cell Therapy
President -
Founder -
See the detail of Luigi Naldini's experience

Training of Luigi Naldini

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

6

1st degree connections

10

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies10

Consumer Services

European Society of Gene & Cell Therapy

Consumer Services

Consumer Services

San Raffaele-Telethon Institute for Gene Therapy

Commercial Services

Health Technology

Health Technology

Health Technology

Health Technology